Stereoselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization
- 5 January 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 486 (1) , 1-8
- https://doi.org/10.1016/j.ejphar.2003.12.006
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Interaction of bepridil with the cardiac troponin C/troponin I complex.FEBS Letters, 2001
- Regulatory Domain Conformational Exchange and Linker Region Flexibility in Cardiac Troponin C Bound to Cardiac Troponin IJournal of Biological Chemistry, 2000
- NMR analysis of cardiac troponin C‐troponin I complexes: effects of phosphorylationFEBS Letters, 1999
- Ca2+Binding and Conformational Changes in a Calmodulin DomainBiochemistry, 1998
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995
- Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendanJournal of Molecular and Cellular Cardiology, 1995
- The troponin complex and regulation of muscle contractionThe FASEB Journal, 1995
- Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair RelaxationJournal of Cardiovascular Pharmacology, 1995
- Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acidsInternational Journal of Peptide and Protein Research, 1990
- Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle.The Journal of general physiology, 1981